A B S T R A C T Approximately 4 h after an initial bronchoalveolar lavage (BAL) of a primate's lung, an appreciable number of polymorphonuclear leukocytes (PMNs) were noted to accumulate in respiratory fluids when lavage was repeated. Whereas, alveolar macrophages (90%) and lymphocytes (7%) were the principal respiratory cells recovered initially from lavage fluid, later samples contained 45-90%o PMNs. To explain the observed ingress of PMNs into lung fluids, concentrated BAL fluid was tested for chemoattractant activity. Such fluid obtained 4 and 24 h after an initial lavage contained material that produced directed migration (chemotaxis) for PMNs and mononuclear cells isolated from peripheral blood of normal donors. Gel filtration chromatography of BAL disclosed two peaks of chemotactic activity in the effluent fractions. Material from the column with an estimated molecular weight of 15,000 daltons was chemotactic for both PMNs and mononuclear cells. Because it was susceptible to inactivation with antiserum against the fifth component of complement, resistant to heating, and unaffected by antiserum against C3, this factor was considered analogous to the cleavage product of the fifth component of complement, C5a. In addition chemotactic activity for PMNs only was contained in an effluent peak having a molecular weight of about 5,000 daltons. This material was heat labile but unaffected by antisera to complement components. To locate the possible source of these factors in respiratory fluid, in vitro cultures of alveolar macrophages were established. These cells, whether stimulated by phago- INTRODUCTION The bronchopulmonary tract has numerous ways to protect itself from various noxious materials contained in respired ambient air (1) . When infectious particles of critical size, usually bacteria, are inhaled and deposited in the distal airways and alveoli, it is generally accepted that resident alveolar macrophages engage these particles, and by phagocytosis and intracellular killing preserve sterility of the lower respiratory tract. However, failure of this cellular mechanism may lead to establishment ofinfection and the development of an inflammatory response, characterized by an accumulation of polymorphonuclear leukocytes (PMNs).' Although this PMN response to acute bacterial infection was elegantly described by Wood (2, 3) years ago, little is known about the mechanisms of accumulation or ingress of these cells into lung tissue and broncho-alveolar secretions or about chemotactic factors which might be involved in this reaction (4) .
The present study was prompted by an observation noted in earlier experiments (5) that a second bronchoalveolar lavage (BAL) performed in normal monkeys within 24 h of a previous lavage yielded respiratory cells which consisted primarily of PMNs and not of alveolar macrophages and lymphocytes as was customary. Monkeys at the time of second BAL had no evidence of infection and no auscultatory or chest X-ray abnormalities. To evaluate the possibility that in vivo production of chemotactic factors was responsible for the accumulation of PMNs, we have examined BAL fluid from serial bronchoalveolar lavages for chemotactic activity and have compared these results with supernatant fluids from alveolar macrophage cultures stimulated by phagocytosis of bacteria. These studies were designed to evaluate the physical characteristics and cellular specificity ofchemotactic factors generated in primate lungs.
METHODS
Animals. Normal rhesus monkeys (Macaca mulatta), aged 1-3 yr, weighing [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] pounds, and ofboth sexes, were used. Adults were born and raised in the breeding facilities of the National Institutes of Health and were maintained in individual cages on a diet of monkey chow supplemented with liquid multivitamins and fresh fruit.
Bronchoalveolarlavage. BAL was performed as described previously (5) . After (9) . The distance (in micrometers) that the leading front of cells had migrated into the filter was determined with a microscope micrometer as previously described (10) . Five 
RESULTS
Cellular content and chemotactic activity in repeated BAL. Typically, from an initial BAL, the respiratory cell differential count consisted of 88-92% alveolar macrophages, 5-8% lymphocytes, and 2-4% PMNs, whereas cell preparations obtained at the second lavage 24 h later contained 90-93% PMNs, 4-9%o alveolar macrophages, and 1-2% lymphocytes. Eosinophils were seen very infrequently.
Since BAL with sterile saline consistently resulted in a marked accumulation of PMNs in bronchial secretions within 24 h ofthe initial lavage, studies were done to monitor changes in the cellular composition of BAL and to measure chemotactic activity in this fluid from serial lavages. In a representative experiment, a monkey underwent four lavage procedures spaced during a 24-h interval and a final lavage at 72 h (Fig. 1) . The total number of respiratory cells recovered and the absolute number of PMNs and alveolar macrophages are given (upper panel, Fig. 1 ) and compared with the chemoattractant activity for PMNs and mononuclear cells in the concentrated BAL (lower panel). The recovery of BAL fluid in each instance was comparable (75+4.0%) and the animal had no evidence of infectious complications. As shown in Fig. 1 (Table II) . For both PMN and mononuclear cells there was significantly less migration by cells exposed to a uniform concentration of BAL (activated random migration) as opposed to cells exposed to a gradient of stimulus (directed migration). Both of these conditions, however, produced significantly more cell migration than when cells were exposed only to buffer (random migration). Thus, the bronchial lavage fluid fulfilled accepted criteria for being a chemotactic factor in that it stimulated random migration and when used under conditions that created a gradient, it converted random migration to directed migration (chemotaxis) (10) .
Partial characterization of the chemotactic activity in bronchial washinigs. To evaluate further the chemotactic activity of bronchial secretions, BAL fluids were pooled from five monkeys in whom lavages were done 24 h after an initial lavage. The concentrated pool of bronchial lavage was fractionated by gel filtration (Sephadex G-75) and the chemotactic activity measured in the effluent fractions (Fig. 2) . Two peaks of chemotactic activity for PMNs were noted, one eluting at 320 ml (peak A) and another eluting at 410 mnl (peak B). Mononuclear cell chemotactic activity was also present in the fractions eluting at 320 ml (designated peak C), but was not detected in other fractions recovered at 410 ml. Calibration of the Sephadex G-75 column with proteins of known molecular weight provided an estimate of the molecular size of the chemotactic factors: 15,000 daltons for peak A and peak C, and less than 5,000 daltons for peak B.
Fractions with chemotactic activity were pooled and concentrated 10-fold (Amicon, UM-05 membrane) for further characterization of the PMIN-chemotactic activity (Table III) Fig. 3A ; data similar to that in Fig. 3 peaks of chemotactic activity for PMNs which eluted at 320 ml (peak A) and at 410 ml (peak B), and one peak of chemotactic activity for mononuclear cells which also eluted at 320 ml (peak C). Further studies were done to determine ifthe chemotactic material released from alveolar macrophages into the culture supematant was preformed in the cell or synthesized after stimulation. Cell lysates prepared from alveolar macrophages regularly had extensive chemotactic activity for both PMNs and monocytes, suggesting there is some storage of the factor within the cell. Bacteria-stimulated alveolar macrophage monolayers (Fig. 3B) were incubated with 15,ug/ml of cycloheximide (U) to study the effects of this protein synthesis inhibitor on the generation of chemotactic activity. Cycloheximide significantly inhibited release of the chemotactic activity into the supematant fluid (P < 0.001) for all points compared with normally stimulated (l) cells. Control experiments, not depicted, showed no reduction in PMN migration when the same concentration of cycloheximide was added to a casein chemotactic stimulus. Thus, the effect of cycloheximide was on the production and (or) release of chemotactic factor(s) from the cell monolayer and not due to a toxic or inhibiting influence of cycloheximide per se on the chemotactic assay.
Polymorphonuclear Leukocytes Chemotactic Factor from Primate Lungs Partial characterization of the chemotactic activity releasedfrom alveolar macrophages in vitro. Supernatant fluids from five alveolar macrophage mono-A layers, initially stimulated with heat-killed S. albus and incubated for 8 h, were pooled, concentrated 50-fold (Amicon, UM-05 membrane) and gel filtered through 4 Sephadex G-75 (Fig. 4) . No change in optical density readings (280 nm) denoted minimal protein elution from the column (contrast with BAL in Fig. 2 ). How---4; ever, a prominent peak of chemotactic activity for PMNs eluted at about 400 ml, corresponding to a -4 molecule of less than 5,000 daltons in weight. No significant chemotactic activity for mononuclear cells were detected in the elution fractions. Column fractions with chemotactic activity (Fig. 4) were pooled and concentrated 10-fold (Amicon, UM-05 membrane); B this material was further characterized in Table IV . The activity was heat labile and was not affected by prior incubation with goat antiserum to human complement components C3 and C5. This concentrated material induced directed migration of PMNs as Alveolar macrophage incubation experiments measuring the chemotactic activity for mononuclear cells in monolayer's supematant fluid showed similar findings. Chemotactic activity was measured after h of incubation and this increased over the duration of the experiment. Considerable activity was again measured in fluid from monolayers not stimulated with bacteria. (Table III) .
To investigate the possible origin of these chemotactic factors in the respiratory tract, in vitro cultures of normal monkey alveolar macrophages were studied. These cells, when adherent to glass surfaces or stimulated by phagocytosis of opsonized killed bacteria, secreted material into culture media (protein-free medium) which was chemotactically active for PMNs, was heat labile, unaffected by treatment with antiserum to human C3 or C5, and had a molecular weight less than 5,000 daltons (Tabjl& IV and Fig. 4) . Moreover, macrophage synthesis a-nd (or) release of this material was prevented by cycloheximide (Fig. 3B) .
It was of interest that the chemotactic activity localized in Peak A after gel filtration of concentrated BAL fluid (Fig. 2) was heat stable and diminished by incubation with antiserum to human C5. It would appear that this material represents the complementderived chemoattractant, C5a, which also has a molecular weight of approximately 15,000 daltons, is heat stable and is diminished in activity by anti-C5 antiserum. C5a has been found to be chemotactic for neutrophils (14) mononuclear cells (11, (14) (15) (16) , and eosinophils (17) . Chemotactically active complement components present in pulmonary secretions may originate from local activation of the complement pathway in the lower respiratory tract. Although low levels (Fig. 4) . ¶ Heating significantly reduced chemotactic activity (P < 0.001) compared to untreated material.
of complement activity can be detected in rabbit (18) and human (19) BAL fluid, appreciable amounts of serum factors could enter the lung with extensive inflammation and be activated by locally secreted material. Several studies (16, 17, 20, 21) have shown granulocytes to contain a material that generated chemotactic activity from whole serum and from isolated C5. Ward and Zvaifler (22) have demonstrated that the enzyme responsible for direct cleavage of C5 to C5a is released in vitro from rabbit PMNs after phagocytosis of immune complexes. In addition it has been shown that human PMNs, during phagocytosis of latex particles, release an enzyme capable of generating chemotactic activity from whole serum primarily by activating the classical and the alternate complement pathways, and by the direct cleavage of C5a from C5 (23) . This enzyme is located in specific granules and released rapidly after phagocytosis (24) . A recent report (25) has shown that activated complement components in turn can induce lysosomal enzyme release from macrophages. Thus, an amplification system mediated through locally released activated complement components in the lung could permit persistance of an inflammatory state. Complement components have been reported to be synthesized by macrophages and their monocyte precursors by several investigators. Primate peritoneal macrophages synthesize the third and fourth components of complement (26) , and human monocytes Polymorphonuclear Leukocytes Chemotactic Factor from Primate Lungs 279 synthesize and secrete the second component of complement (C2) (27) . It is conceivable that yet another complement protein, C5, might be produced by alveolar macrophages and secreted locally into lung secretions. The localization of C5 in alveolar macrophages would help to prove this point.
In addition to complement-related mediators, our experiments establish that another heat labile, small molecular weight chemotactic factor is produced locally in vivo and is apparently derived from alveolar macrophages as shown by in vitro experiments. The requirement of cells for production of this factor was clearly established. Little chemotactic activity was measured in supernates from stimulated macrophage cultures incubated with 15 ,ug/ml of cycloheximide (Fig. 3B) , demonstrating that protein synthesis is involved in the generation or the release of this factor (28, 29) . Alveolar macrophages, whether cultured on glass surfaces or stimulated by phagocytosis ofbacteria, produced considerable chemotactic activity compared to the same number of macrophages incubated as a free cell suspension (Fig. 3B ). This suggests that just the attachment to a glass surface is enough stimulation to induce release of a sizeable amount of active factor.
The relationship between the active material, described in these experiments, produced by macrophage monolayers and chemotactic materials described by others is unclear at present. This chemotactic factor which preferentially attracts PMNs has properties similar to those described for dialyzable transfer factor (30) . Although this chemotactic factor may also have properties in common with the small molecular weight eosinophilotactic tetrapeptides (ECFA) (31) , the material appears to differ from ECFA. Eosinophils were not prominent among the respiratory cells recovered with repeated lavage. Moreover, in studies using eosinophil-enriched cell preparations and measuring leukocyte locomotion under agarose (32) , which enables precise identification of cell types, our chemotactic factor did not cause preferential attraction of eosinophils in the mass of migrating cells.3 Macro- phages have been shown to secrete a number of biologically active substances, including lysozyme (33) , collagenase (34) , plasminogen activator (35) , elastase (36) , endogenous pyrogen (37) , and the complement components C3 and C4 (26) . The small molecular weight of the macrophage chemotactic factor we have described distinguishes it from some of the other macrophage products listed above. Thus, this factor is another biologically active molecule, secreted by alveolar macrophages, which may be important in lung defenses.
